Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Dec 21;20(9):2121–2131.e3. doi: 10.1016/j.cgh.2021.12.021

Table 2.

Study outcomes

Total (n = 470) Food or Lactose Intolerance P-value
No (n = 273) Yes (n = 197)
Irritable bowel syndrome (IBS) 56 (11.9%) 11 (4.0%) 45 (22.8%) <0.001
HADS anxiety score, median (IQR) 7.0 (2.0 – 11.0) 4.0 (1.0 – 9.0) 9.0 (5.0 – 12.0) <0.001
HADS anxiety <0.001
 Normal (0–7) 256 (54.5%) 179 (65.6%) 77 (39.1%)
 Borderline abnormal (8–10) 85 (18.1%) 41 (15.0%) 44 (22.3%)
 Abnormal (11–21) 129 (27.4%) 53 (19.4%) 76 (38.6%)
HADS depression score, median (IQR) 5.0 (1.0 – 9.0) 3.0 (1.0 – 8.0) 7.0 (3.0 – 10.0) <0.001
HADS depression <0.001
 Normal (0–7) 306 (65.1%) 197 (72.2%) 109 (55.3%)
 Borderline abnormal (8–10) 98 (20.9%) 45 (16.5%) 53 (26.9%)
 Abnormal (11–21) 66 (14.0%) 31 (11.4%) 35 (17.8%)
SF-12, mean (sd)
 Physical component score 48.6 (8.6) 50.8 (7.9) 45.6 (8.5) <0.001
 Mental component score 46.5 (11.4) 48.3 (11.8) 43.9 (10.4) <0.001

HADS, Hospital Anxiety and Depression Scale; SF-12, Short Form 12. Median and interquartile range (IQR) are reported for continuous variables with a skewed distribution and mean and standard deviation (SD) are reported for normally distributed continuous variables. P-values are calculated based on the Wilcoxon rank sum test or two-sample t-test for continuous variables. For categorical variables, we used the Pearson’s chi-square test.